| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be1ce2a6777dc54f30fa29ba1beccd54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bccb422d1c0d02017f7a48a67eb67f74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5d40be889e94962bc2e9cd2af6f54b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c27632600176291b7469551999ae9901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbdbc603fbbd3d05bb7f1d26da112eef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4105beb7f170f112076788a477e7005f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fc3feb6ac091fd9da6b6bb4460279 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-315 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315 |
| filingDate |
2007-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf2b8eb39f016343a0f1edab02e84dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6664b3bd6d463dfd37462fc55671942e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f836a7fa69e3ffd41a98ead43e7fc3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5bc477950f9e9884f7ead8d1e7b84c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_638074175a627d98e221c9a5075ed22d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2cc3643d53ad0eea3c348d071c4a14 |
| publicationDate |
2013-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8529911-B2 |
| titleOfInvention |
Small Streptococcus pyogenes antigens and their use |
| abstract |
The present invention relates to a peptide consisting of one antigen of Streptococcus pyogenes ( S. pyogenes ) of any of the SEQ ID NOS: 1 to 7 or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing a S. pyogenes infection; a method for identifying a ligand capable of binding to said peptide; and the use of said peptide for the isolation and/or purification and/or identification of an interaction partner of the peptide. |
| priorityDate |
2006-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |